Arcutis Biotherapeutics advances 11% to new 52-week high
Reported by Seeking Alpha · seekingalpha.com ·
Story context
What to watch: This report cites a concrete figure (11%) — compare it against the trailing trend before treating one data point as a turning point.
Latest session change: $ARQT +12.71%
How this was labelled
Seeking Alpha published it, and Wook filed it under Markets. It reads bullish at medium severity because of “high” in the wording, with nothing on the bearish side to offset it. It was matched to $ARQT. It carried 11%, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
When it landed
It landed after the close, so the session change beside it was final before the story existed. The next session is the first that could react.
Where the price is
$ARQT last traded at $32.48, +12.71% on the session. That is 1.6% below its 52-week high of $33.00 and 68% above its low of $19.30 — within a tenth of its 52-week high. The year's range spans 71% from low to high: a wide band — moves of several percent in a week are ordinary at that volatility. These are latest-session quotes, not live prices.
How much is being written
Wook has stored 2 stories about $ARQT in the last 30 days, 2 of them this week. At the 30-day pace you would expect about 0 a week, so this week is running well ahead of normal — something has drawn extra attention. Across those stories the wording ran 100% bullish, 0% neutral and 0% bearish; this one reads bullish, so it sits with the majority of the run. This is the only one from Seeking Alpha; the rest came from other outlets. 12 of them are listed beside this one.
The backdrop
Market-wide stories are about the forces that move everything at once — rates, growth, inflation and appetite for risk — rather than one company, so their effect tends to show up in the indexes before it shows up in any single name. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it reads.
What is already on the calendar
$ARQT earnings in 8 days. These were scheduled before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company will arrive soon.
Where to look next
The $ARQT page has the full chart, the filings and the valuation model behind these figures. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and do the math — how far $ARQT is from its high, or how this week's coverage compares — on request.
What this page is not saying
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on October 19, 2026. $ARQT has moved +0.91% ($32.19 to $32.48). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.